By Charles S. Wilcox, Ph.D/ November, 2017 Since the approval of Namenda in 2003, there has not been any new and novel medication approved for the treatment of mild-to-moderate, or moderate-to-severe Alzheimer’s disease. During these subsequent fourteen years, there has
By Dr. Trinh/ November, 2017 There are three main stages of Alzheimer’s progression: the mild stage, the moderate stage, and the severe stage. Prior to these three stages of the disease is a pre-Alzheimer’s stage, called “Mild Cognitive Impairment” (MCI). During MCI, individuals may occasionally experience memory problems which do not affect their activities of
By Dr. Trinh/ November, 2017 In neuroscience research, a new direction in Alzheimer’s clinical trials is to detect the disease early enough to possibly prevent it from progressing. Now, more and more research companies, including Irvine Clinical Research (ICR), are shifting their focus to trying to find and identify Alzheimer’s while symptoms are still mild
